This November for Lung Cancer Awareness Month, discover the latest treatments, research insights, and our impact on…
CRI ImmunoAdvocate Oswald Peterson discusses his experience receiving a PD-1 checkpoint inhibitor for stage 4 non-small cell…
This November for Lung Cancer Awareness Month, we look at the rapidly changing treatment landscape, adapting cancer…
Dr. Leena Gandhi, of Dana-Farber Cancer Institute, answers questions about immunotherapy for lung cancer from the 2020…
CRI spoke with Dr. Joshua Sabari about how clinical care for lung cancer patients has been impacted…
The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…
We round up the latest news and research from the people changing the future of lung cancer…
